Scholarlink

<p>Seven new polycyclic-fused cytochalasins (CYTs), harziachalasins A–G (<b>1</b>–<b>7</b>), together with three known analogues (<b>8</b>–<b>10</b>) were isolated from the solid culture of the endophytic fungus <i>Trichoderma harzianum</i> MLJ-4, which was originally isolated from the leaves of <i>Asclepias curassavica</i>. The planar and absolute structures of all new compounds were determined on the basis of extensive spectroscopic data (1D, 2D NMR and HR-ESI–MS), NMR calculations with DP4 + probability analysis, and theoretical simulations of ECD spectra. Compound <b>1</b> represents the first example of 5/6/6 tricyclic CYT featuring a 2-methyl-4-oxopentyl side chain at the C-14 position. This novel architecture originates from a 5/6/6/7 tetracyclic CYT precursor through sequential oxidative cleavage of the C-19–C-20 bond followed by decarboxylative elimination of C-19. Compound <b>2</b> features an unprecedented 5/6/6/6/7 pentacyclic scaffold incorporating a 1,3-dioxane moiety, may be constructed by the acetalization of the 7-OH and 13-OH on a 5/6/6/7 tetracyclic CYT with acetaldehyde. Compounds <b>1</b>–<b>10</b> were screened for HIV latency reversal activity using J-Lat A72 and J-Lat 10.6 cell models. Compound <b>4</b> showed strong activity, with half-maximal effective concentrations (EC<sub>50</sub>) values of 2.68&#xa0;μM (J-Lat A72 cells) and 2.99&#xa0;μM (J-Lat 10.6 cells), demonstrating consistent potency. Mechanistic studies revealed <b>4</b> activated the NF-<i>κ</i>B pathway to reverse HIV latency, offering insights for new therapeutic strategies targeting this pathway.</p> Graphic Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Harziachalasins A–G, polycyclic-fused cytochalasins from the endophytic fungus Trichoderma harzianum MLJ-4 with HIV latency reversal activity

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月11日

查看全文
  • Yan-Jiang Zhang,
  • Xian-Yuan Yang,
  • Yi-Fan Fu,
  • Qiong Liao,
  • Jia-Qian Chen,
  • Xian-An Chen,
  • Dong Huang,
  • Tao Yuan,
  • Xin Chen,
  • Sheng Yin,
  • Gui-Hua Tang

摘要

Seven new polycyclic-fused cytochalasins (CYTs), harziachalasins A–G (1–7), together with three known analogues (8–10) were isolated from the solid culture of the endophytic fungus Trichoderma harzianum MLJ-4, which was originally isolated from the leaves of Asclepias curassavica. The planar and absolute structures of all new compounds were determined on the basis of extensive spectroscopic data (1D, 2D NMR and HR-ESI–MS), NMR calculations with DP4 + probability analysis, and theoretical simulations of ECD spectra. Compound 1 represents the first example of 5/6/6 tricyclic CYT featuring a 2-methyl-4-oxopentyl side chain at the C-14 position. This novel architecture originates from a 5/6/6/7 tetracyclic CYT precursor through sequential oxidative cleavage of the C-19–C-20 bond followed by decarboxylative elimination of C-19. Compound 2 features an unprecedented 5/6/6/6/7 pentacyclic scaffold incorporating a 1,3-dioxane moiety, may be constructed by the acetalization of the 7-OH and 13-OH on a 5/6/6/7 tetracyclic CYT with acetaldehyde. Compounds 1–10 were screened for HIV latency reversal activity using J-Lat A72 and J-Lat 10.6 cell models. Compound 4 showed strong activity, with half-maximal effective concentrations (EC50) values of 2.68 μM (J-Lat A72 cells) and 2.99 μM (J-Lat 10.6 cells), demonstrating consistent potency. Mechanistic studies revealed 4 activated the NF-κB pathway to reverse HIV latency, offering insights for new therapeutic strategies targeting this pathway.

Graphic Abstract